APA (7th ed.) Citation

J, S., C, G., SR, H., T, L., TJA, M., I, H., . . . KJ, D. (2022). ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants. Cell reports, 39(5), 110757. https://doi.org/10.1016/j.celrep.2022.110757

Chicago Style (17th ed.) Citation

J, Seow, et al. "ChAdOx1 NCoV-19 Vaccine Elicits Monoclonal Antibodies with Cross-neutralizing Activity Against SARS-CoV-2 Viral Variants." Cell Reports 39, no. 5 (2022): 110757. https://doi.org/10.1016/j.celrep.2022.110757.

MLA (9th ed.) Citation

J, Seow, et al. "ChAdOx1 NCoV-19 Vaccine Elicits Monoclonal Antibodies with Cross-neutralizing Activity Against SARS-CoV-2 Viral Variants." Cell Reports, vol. 39, no. 5, 2022, p. 110757, https://doi.org/10.1016/j.celrep.2022.110757.